Literature DB >> 3503432

Apolipoprotein E polymorphism and atherosclerosis: insight from a study in octogenarians.

J Davignon1, D Bouthillier, A C Nestruck, C F Sing.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3503432      PMCID: PMC2376437     

Source DB:  PubMed          Journal:  Trans Am Clin Climatol Assoc        ISSN: 0065-7778


× No keyword cloud information.
  32 in total

1.  Apolipoprotein E phenotypes and hyperlipidemia.

Authors:  G Utermann; I Kindermann; H Kaffarnik; A Steinmetz
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

2.  Hyper-alpha-lipoproteinemia and hypo-beta-lipoproteinemia are not markers for a high life expectancy. Serum lipid and lipoprotein findings in 103 randomly selected nonagenarians.

Authors:  H Heckers; W Burkard; F W Schmahl; W Fuhrmann; D Platt
Journal:  Gerontology       Date:  1982 May-Jun       Impact factor: 5.140

3.  Apolipoprotein E phenotypes in patients with myocardial infarction.

Authors:  G Utermann; A Hardewig; F Zimmer
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

4.  Reference intervals for serum lipids, lipoproteins, and apoproteins in the elderly.

Authors:  C Alvarez; A Orejas; S Gonzalez; R Diaz; L F Colomo
Journal:  Clin Chem       Date:  1984-03       Impact factor: 8.327

5.  Apolipoprotein E phenotyping with a single gel method: application to the study of informative matings.

Authors:  D Bouthillier; C F Sing; J Davignon
Journal:  J Lipid Res       Date:  1983-08       Impact factor: 5.922

Review 6.  Apolipoprotein E polymorphism and atherosclerosis.

Authors:  J Davignon; R E Gregg; C F Sing
Journal:  Arteriosclerosis       Date:  1988 Jan-Feb

Review 7.  Type III hyperlipoproteinemia: recent insights into the genetic defect of familial dysbetalipoproteinemia.

Authors:  R W Mahley; B Angelin
Journal:  Adv Intern Med       Date:  1984

8.  Increased frequency of lipoprotein disorders similar to type III hyperlipoproteinemia in survivors of myocardial infarction in Japan.

Authors:  K Kameda; Y Matsuzawa; M Kubo; K Ishikawa; I Maejima; T Yamamura; A Yamamoto; S Tarui
Journal:  Atherosclerosis       Date:  1984 May-Jun       Impact factor: 5.162

9.  Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation.

Authors:  C F Sing; J Davignon
Journal:  Am J Hum Genet       Date:  1985-03       Impact factor: 11.025

10.  Lipoprotein predictors of the severity of coronary artery disease in men and women.

Authors:  M F Reardon; P J Nestel; I H Craig; R W Harper
Journal:  Circulation       Date:  1985-05       Impact factor: 29.690

View more
  21 in total

Review 1.  Genetic epidemiology in aging research.

Authors:  M Daniele Fallin; Amy Matteini
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2009-01-23       Impact factor: 6.053

2.  Low apolipoprotein E epsilon4 allele frequency in the population of Catalonia (Spain) determined by PCR-RFLP and Laser fluorescent sequencer.

Authors:  M Gené; P Moreno; M Ezquerra; A Prat; E Huguet; R Adroer; R Oliva
Journal:  Eur J Epidemiol       Date:  1997-10       Impact factor: 8.082

3.  Genotype-environment interaction: apolipoprotein E (ApoE) gene effects and age as an index of time and spatial context in the human.

Authors:  K E Zerba; R E Ferrell; C F Sing
Journal:  Genetics       Date:  1996-05       Impact factor: 4.562

4.  One step closer to fixing association studies: evidence for age- and gender-specific allele frequency variations and deviations from Hardy-Weinberg expectations in controls.

Authors:  Haydeh Payami; Motao Zhu; Jennifer Montimurro; Robert Keefe; Colin C McCulloch; Lina Moses
Journal:  Hum Genet       Date:  2005-09-28       Impact factor: 4.132

5.  A prospective study of cognitive health in the elderly (Oregon Brain Aging Study): effects of family history and apolipoprotein E genotype.

Authors:  H Payami; H Grimslid; B Oken; R Camicioli; G Sexton; A Dame; D Howieson; J Kaye
Journal:  Am J Hum Genet       Date:  1997-04       Impact factor: 11.025

6.  Genetic risk factors for perinatal arterial ischemic stroke.

Authors:  Amy A Gelfand; Lisa A Croen; Anthony R Torres; Yvonne W Wu
Journal:  Pediatr Neurol       Date:  2013-01       Impact factor: 3.372

7.  Gender difference in apolipoprotein E-associated risk for familial Alzheimer disease: a possible clue to the higher incidence of Alzheimer disease in women.

Authors:  H Payami; S Zareparsi; K R Montee; G J Sexton; J A Kaye; T D Bird; C E Yu; E M Wijsman; L L Heston; M Litt; G D Schellenberg
Journal:  Am J Hum Genet       Date:  1996-04       Impact factor: 11.025

8.  High-density genomewide linkage analysis of exceptional human longevity identifies multiple novel loci.

Authors:  Steven E Boyden; Louis M Kunkel
Journal:  PLoS One       Date:  2010-08-31       Impact factor: 3.240

9.  Apolipoprotein E epsilon4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging.

Authors:  Ging-Yuek R Hsiung; A Dessa Sadovnick; Howard Feldman
Journal:  CMAJ       Date:  2004-10-12       Impact factor: 8.262

10.  The gender-specific apolipoprotein E genotype influence on the distribution of plasma lipids and apolipoproteins in the population of Rochester, MN. III. Correlations and covariances.

Authors:  S L Reilly; R E Ferrell; C F Sing
Journal:  Am J Hum Genet       Date:  1994-11       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.